
Roy Howard Perlis MD
Director of the Center for Experimental Drugs and Diagnostics (CEDD) and Associate Director of the Psychiatric Genetics Program in Mood and Anxiety Disorders in the MGH Psychiatry Department Associate Professor of Psychiatry at Harvard Medical School and serves as a consultant to the American Psychiatric Association's bipolar treatment guidelines workshop
Join to View Full Profile
15 Parkman Street Wac 812Psychiatry Outpatient DepartmentBoston, MA 02114
Phone+1 617-724-5600
Fax+1 617-724-3028
Dr. Perlis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1997 - 2001
Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1997 - 1998
Harvard Medical SchoolClass of 1997
Certifications & Licensure
AR State Medical License 2025 - 2028
WA State Medical License 2025 - 2028
FL State Medical License 2025 - 2028
MI State Medical License 2025 - 2028
MA State Medical License 1998 - 2028
SC State Medical License 2025 - 2027
ND State Medical License 2025 - 2027
American Board of Psychiatry and Neurology Psychiatry- Join now to see all
Clinical Trials
- Effectiveness of Pramipexole for Treatment-Resistant Depression Start of enrollment: 2003 Sep 01
- Simvastatin Augmentation of Lithium Treatment in Bipolar Depression Start of enrollment: 2012 Aug 01
- Adjunctive Isradipine for the Treatment of Bipolar Depression Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- Correction: A brain-enriched circRNA blood biomarker can predict response to SSRI antidepressants.Grigorios Papageorgiou, El Chérif Ibrahim, Victor Gorgievski, Gabriella Maxson, Evelyn Lozano
Molecular Psychiatry. 2026-03-30 - Sociodemographic disparities, healthcare system trust, and social support in mental health treatment among U.S. adults with depressive or anxiety symptoms.Anudeepa K Ramachandiran, Faith Gunning, Mauricio Santillana, Matthew A Baum, Pilar F Verhaak
Journal of Mood and Anxiety Disorders. 2026-03-01 - Psychiatric Documentation and Management in Primary Care With Artificial Intelligence Scribe Use.Victor M Castro, Thomas H McCoy, Pilar Verhaak, Anudeepa Ramachandiran, Roy H Perlis
JAMA Psychiatry. 2026-03-01
Journal Articles
- Psychiatry and COVID-19Roy Perlis, Donald Goff, JAMA
- Can Electronic Health Records Revive Central Nervous System Clinical Trials?Maurizio Fava, Roy H Perlis, Nature
- Temporal Trends and Characteristics of Reportable Health Data Breaches, 2010-2017Roy Perlis, MD, JAMA
Lectures
- Effect of Cytochrome CYP2C19 Metabolizing Activity on Antidepressant Response and Side Effects: Meta-Analysis of Data from Genome-Wide Association Studies162nd Annual Meeting, San Francisco, California, USA
- Discovery of a Highly Selective Glycogen Synthase Kinase‐3 Inhibitor (PF‐04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingAmerican Psychiatric Association, 162nd Annual Meeting, San Francisco, California, USA
Authored Content
- The Time Has Come for Over-the-Counter AntidepressantsApril 2024
- Genome-Wide Association Study of Dimensional Psychopathology Using Electronic Health RecordsFebruary 2018
- High Throughput Phenotyping for Dimensional Psychopathology in Electronic Health RecordsFebruary 2018
Press Mentions
JAMA at Kidney Week, JAMA Summit Report on Firearm Violence Reduction, AI for Drug Discovery, and MoreNovember 7th, 2025
Is COVID-19 During Pregnancy Linked to Autism? What a New Study Shows, and What It Doesn'tNovember 3rd, 2025
Researchers Say Covid Infection During Pregnancy Is Tied to Autism — but They Aren’t yet Sure WhyOctober 31st, 2025
Grant Support
- Scalable Phenotyping to Assay Risk in Childhood after eXposures in Pregnancy: SPARC-XPMASSACHUSETTS GENERAL HOSPITAL2025–2029
- JASPer-MH: Jointly Assessed Scalable Phenotypes for Mental HealthMASSACHUSETTS GENERAL HOSPITAL2024–2029
- JASPer-MH: Jointly Assessed Scalable Phenotypes for Mental HealthMASSACHUSETTS GENERAL HOSPITAL2024–2029
- Characterization of schizophrenia liability genes in models of human microglial synaptic pruningMASSACHUSETTS GENERAL HOSPITAL2023–2028
- Depression, Isolation, and Social Connectivity Online (DISCO)MASSACHUSETTS GENERAL HOSPITAL2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:


































